Quadrant Capital Group LLC
- SEC CIK
- 0001650717
- Latest filing
- Aug 14, 2026
KNTE holding history
Kinnate Biopharma Inc. in every 13F filed by Quadrant Capital Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KNTE overviewAll 13F holders of KNTEFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −428−100.0% | Sold out | Holders |
| Q3 2022 | 428 | $5.00K | <0.1% | −231−35.1% | Reduced | Holders |
| Q2 2022 | 659 | $8.00K | <0.1% | −357−35.1% | Reduced | Holders |
| Q1 2022 | 1,016 | $11.0K | <0.1% | +549+117.6% | Added | Holders |
| Q4 2021 | 467 | $8.00K | <0.1% | +445+2,022.7% | Added | Holders |
| Q3 2021 | 22 | $1.00K | <0.1% | +22 | New | Holders |